Corpus Intelligence IC Memo — BEAR RIVER VALLEY HOSPITAL 2026-04-26 04:04 UTC
IC Memo — BEAR RIVER VALLEY HOSPITAL
Investment Committee Memorandum | UT | 16 beds | Grade C | EBITDA uplift $2.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BEAR RIVER VALLEY HOSPITAL

CCN 460039 | BOX ELDER, UT | 16 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BEAR RIVER VALLEY HOSPITAL is a 16-bed suburban community hospital in BOX ELDER, UT with $34.2M in net patient revenue and a 9.5% operating margin. The hospital serves a payer mix of 14.9% Medicare, 9.7% Medicaid, and 75.4% commercial.

Thesis: Turnaround. Our ML models identify $2.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.5% to 16.9% (+736bps).

Net Revenue HCRIS$34.2M
Current EBITDA COMPUTED$3.2M
Operating Margin COMPUTED9.5%
Occupancy HCRIS16.3%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS50.7%
Distress Probability ML57.4%

2. Market Context & Competitive Position

59
UT Hospitals
8.0%
State Median Margin
18
Comparable Hospitals

UT has 59 Medicare-certified hospitals with a median operating margin of 8.0%. The target's margin of 9.5% places it above the state median. Among 18 size-comparable peers (8-32 beds), the median margin is -1.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-32), prioritizing same-state peers. 18 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BEAR RIVER VALLEY HOSPITAL (Target)UT16$34.2M9.5%
GUNNISON VALLEY HOSPITALUT25$130.4M-6.4%
SPANISH FORK HOSPITALUT16$65.3M0.5%
CENTRAL VALLEY MEDICAL CENTERUT25$60.7M4.3%
SEVIER VALLEY HOSPITALUT24$58.2M14.5%
HEBER VALLEY HOSPITALUT19$55.8M8.4%
MOAB REGIONAL HOSPITALUT17$44.2M-3.4%
CACHE VALLEY HOSPITALUT28$34.7M-12.4%
OREM COMMUNITY HOSPITALUT24$34.2M4.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$717K+210bp18mo
Cost to Collect4.5%2.5%$683K+200bp12mo
Denial Rate Reduction12.0%6.5%$676K+198bp12mo
A/R Days Reduction5200.0%3800.0%$416K+122bp9mo
Clean Claim Rate88.0%96.0%$22K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$717K
Cost to Collect
$683K
Denial Rate Reduction
$676K
A/R Days Reduction
$416K
Clean Claim Rate
$22K
Total EBITDA Uplift$2.5M
Current EBITDA$3.2M
+ RCM Uplift+$2.5M
Pro Forma EBITDA$5.8M
Current Margin9.5%
Pro Forma Margin16.9%
WC Released (1x)$1.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$5.0M$46.6M9.32x56.3%
Base (11x exit)10.0x11.0x$5.0M$52.9M10.57x60.3%
Bull Case9.0x11.0x$4.5M$62.8M13.95x69.4%
Bull (12x exit)9.0x12.0x$4.5M$69.8M15.52x73.0%
Bear Case11.0x10.0x$5.5M$32.4M5.89x42.6%
Bear (11x exit)11.0x11.0x$5.5M$37.4M6.80x46.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 16.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 18 hospitals with 8-32 beds
  • Same-state prioritization (n=19)
  • Comp margins: P25=-11.3% / P50=-1.9% / P75=4.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.